Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Support Care Cancer. 2019 Jun 3;28(2):845–855. doi: 10.1007/s00520-019-04834-w

Table 1.

Participant characteristics

Variable T1
(N = 152)
T2
(n = 128)
Sociodemographic variables
  Whitea 122 (80.3) 100 (78.1)
  Educationa
   < College graduate 74 (48.7) 64 (50.0)
   ≥ College graduate 78 (51.3) 64 (50.0)
  Marrieda 105 (69.1) 89 (69.5)
  Ageb 50.84 (9.39) 50.74 (9.19)
Medical variables
  Cancer stage at diagnosisa
   I 42 (27.6) 31 (24.2)
   II 66 (43.4) 57 (44.5)
   III 35 (23.0) 32 (25.0)
  Type of chemotherapy receiveda
   AC 35 (23.0) 31 (24.2)
   AC + Taxotere 30(19.7) 23 (18.0)
   AC + Taxol 45 (29.6) 41 (32.0)
   Other 32(21.1) 25 (19.5)
  First treatment receiveda
   Lumpectomy 62 (40.8) 53 (41.4)
   Mastectomy 63 (41.4) 52 (40.6)
   Other 19(12.5) 16(12.5)
    Double mastectomy 7(4.6) 7(5.5)
    Neoadjuvant chemotherapy 12(7.9) 9 (7.0)
  Medications takena
   Analgesic 102 (67.1) 45 (35.2)
   Antidepressant 29(19.1) 21 (16.4)
   Minor tranquilizers 36(23.7) 32 (25.0)
  Medical comorbiditiesa
   Arthritis 27(17.8) 20(15.6)
   Asthma 16(10.5) 14(10.9)
   Other diseases 21 (13.8) 24(18.8)
  BMIb 28.19(7.11) 28.11 (7.08)

Note.

a

n (%);

b

M(SD);

BMI: Body Mass Index